Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin
- 1 May 2001
- journal article
- case report
- Published by Elsevier in Thrombosis Research
- Vol. 102 (3) , 211-219
- https://doi.org/10.1016/s0049-3848(01)00247-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Measuring Plasma Fibrinogen to Predict Stroke and Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The contribution of thrombosis to the clinical expression of coronary atherosclerosisThrombosis Research, 1996
- Congenital afibrinogenemiaAmerican Journal of Hematology, 1994
- Fibrinogen as a Cardiovascular Risk FactorAnnals of Internal Medicine, 1993
- Fibrin and Its Derivatives in the Normal and Diseased Vessel WallAnnals of the New York Academy of Sciences, 1992
- Fibrinogen as a major risk factor in cardiovascular diseaseTrends in Pharmacological Sciences, 1990
- Measuring plasma fibrinogen to predict stroke and myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymologyBritish Journal of Haematology, 1985
- A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosisBritish Journal of Haematology, 1983
- Platelet activation detected by turbidometric shape-change analysis. Differential influence of cytochalasin B and prostaglandin E1Thrombosis Research, 1978